Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Optimi Health ( (TSE:OPTI) ) has issued an announcement.
Optimi Health has successfully closed its non-brokered private placement, raising a total of $934,000 through the issuance of Units, which include common shares and warrants. The proceeds will be used for general working capital. Additionally, the company has completed a debt settlement with two creditors, retiring $98,501.25 of debt by issuing common shares. This financial maneuvering underscores the company’s strategic efforts to stabilize its financial standing and maintain its growth trajectory in the psychedelics pharmaceutical industry.
More about Optimi Health
Optimi Health Corp. is a GMP-approved, Health Canada licensed psychedelics pharmaceutical manufacturer that specializes in botanical psilocybin and MDMA.
YTD Price Performance: 0.0%
Average Trading Volume: 68,201
Technical Sentiment Consensus Rating: Buy
Current Market Cap: C$21.77M
Learn more about OPTI stock on TipRanks’ Stock Analysis page.
